Pancreatic Cancer Research

ResearcherShizuoka Cancer CenterActive in the last 2 years

Keita P. Mori

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5473-1488; OpenAlex author ID A5078077911. Sources: OpenAlex.

Their work

Papers
6 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
43
Papers, trials and grants by year

2018: 1 paper · 2019: 1 paper · 2020: 1 paper · 2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: 1 paper · 2026: 1 paper

Papers 6

  1. Safety and Efficacy of Concomitant Administration of Nanoliposomal Irinotecan + 5-Fluorouracil/Levo-Leucovorin for Pancreatic Cancer. Co-author DOI 10.1002/cnr2.70485↗
  2. Assessment of safety and patency of 7-mm covered metal stents for preoperative biliary drainage in pancreatic cancer: Prospective multicenter study. Last author DOI 10.1055/a-2503-1995↗
  3. Comparison of five-phase computed tomography images of type 1 autoimmune pancreatitis and pancreatic cancer: Emphasis on cases with atypical images. Co-author DOI 10.1016/j.pan.2021.01.016↗
  4. Human equilibrative nucleoside transporter-1 expression is a predictor in patients with resected pancreatic cancer treated with adjuvant S-1 chemotherapy. Co-author DOI 10.1111/cas.14258↗
  5. A randomized phase II study of nutritional and exercise treatment for elderly patients with advanced non-small cell lung or pancreatic cancer: the NEXTAC-TWO s… Co-author DOI 10.1186/s12885-019-5762-6↗
  6. Nationwide Multicenter Observational Study of FOLFIRINOX Chemotherapy in 399 Patients With Unresectable or Recurrent Pancreatic Cancer in Japan. Co-author DOI 10.1097/mpa.0000000000001049↗

Closest collaborators

The 25 strongest of 43 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hirotoshi Ishiwatari · 2 shared papers, 2021–2025 · strength 0.33
  2. Tatsunori Satoh · 2 shared papers, 2021–2025 · strength 0.33
  3. Takeshi Kawakami · 1 shared paper, 2026 · strength 0.32
  4. Akane Wakabayashi · 1 shared paper, 2026 · strength 0.32
  5. Fumitaka Niiya · 1 shared paper, 2025 · strength 0.22
  6. Shinya Uemura · 1 shared paper, 2025 · strength 0.22
  7. Junya Sato · 1 shared paper, 2025 · strength 0.22
  8. Shinya Endo · 1 shared paper, 2025 · strength 0.22
  9. Takuji Iwashita · 1 shared paper, 2025 · strength 0.22
  10. Shinya Kawaguchi · 1 shared paper, 2025 · strength 0.22
  11. Akira Fukutomi · 2 shared papers, 2018–2020 · strength 0.15
  12. Shoji Nakamori · 2 shared papers, 2018–2020 · strength 0.15
  13. Narikazu Boku · 2 shared papers, 2018–2020 · strength 0.15
  14. Teiichi Sugiura · 1 shared paper, 2021 · strength 0.10
  15. Hiroyuki Matsubayashi Md · 1 shared paper, 2021 · strength 0.10
  16. Hiroyuki Ono · 1 shared paper, 2021 · strength 0.10
  17. Amane Takahashi · 1 shared paper, 2020 · strength 0.08
  18. Yuji Kaneoka · 1 shared paper, 2020 · strength 0.08
  19. Masato Nagino · 1 shared paper, 2020 · strength 0.08
  20. Hiroto Narimatsu · 1 shared paper, 2020 · strength 0.08
  21. Naohiro Sata · 1 shared paper, 2020 · strength 0.08
  22. Katsuhiko Uesaka · 1 shared paper, 2020 · strength 0.08
  23. Hirochika Toyama · 1 shared paper, 2020 · strength 0.08
  24. Yukiyasu Okamura · 1 shared paper, 2020 · strength 0.08
  25. Soichiro Morinaga · 1 shared paper, 2020 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.